| Patents for A61K 38 - Medicinal preparations containing peptides (316,240) |
|---|
| 05/03/2005 | US6887994 C-nitroso compounds and use thereof |
| 05/03/2005 | US6887987 DNA encoding the human serine protease T |
| 05/03/2005 | US6887983 Purified 20 kDA presenilin 2 C-terminal fragment and methods of screening for compounds that inhibit proteolysis of presenilin 2 |
| 05/03/2005 | US6887982 Antibodies reactive to the c-terminal portion of growth factor homolog zvegf3 |
| 05/03/2005 | US6887981 Natural antibacterial peptide, the nucleotide sequence encoding it and the use thereof |
| 05/03/2005 | US6887977 Methods and materials relating to CD8-tropic HIV-1 |
| 05/03/2005 | US6887976 Improved mammalian safety profile; glycopeptide phosphonate derivatives of invention unexpectedly exhibit reduced tissue accumulation and/or nephrotoxicity when administered to mammal; antibacterial agents |
| 05/03/2005 | US6887975 Serpentine protein for use in the treatment of cancer |
| 05/03/2005 | US6887890 For therapy of thrombocytopenia |
| 05/03/2005 | US6887887 Asymmetric synthesis of (S,S,R)-(-)-actinonin and its analogs and uses therefor |
| 05/03/2005 | US6887877 Viricide for hepatitis virus |
| 05/03/2005 | US6887856 Protection from ionizing irradiation or chemotherapeutic drug damage by in vivo gene therapy |
| 05/03/2005 | US6887852 Pharmaceutical preparation of recombinant factor VIII lyophilized without albumin as a stabilizer |
| 05/03/2005 | US6887851 IGF-binding protein-derived peptide |
| 05/03/2005 | US6887849 Long lasting synthetic glucagon-like peptide {GLP-1} |
| 05/03/2005 | US6887848 Vascular endothelial growth factor variants |
| 05/03/2005 | US6887847 Virus derived antimicrobial peptides |
| 05/03/2005 | US6887846 Antimicrobial amino acid sequences derived from alpha-melanocyte-stimulating hormone |
| 05/03/2005 | US6887845 Polypeptoid pulmonary surfactants |
| 05/03/2005 | US6887844 To stimulate the proliferation or/and the outgrowth from cells presenting the neural cell adhesion molecule (NCAM) |
| 05/03/2005 | US6887843 Chlamydia protein, gene sequence and uses thereof |
| 05/03/2005 | US6887704 A cell population cultured ex-vivo in a culture medium under conditions permitting cells of cell population to proliferate and at the same time reducing capacity of cells in utilizing copper, hence expanded yet not further differentiated |
| 05/03/2005 | US6887695 Transglutaminase ztg2 |
| 05/03/2005 | US6887687 Nucleic acids encoding human ataxin-1-like polypeptide IMX97018 |
| 05/03/2005 | US6887684 Nucleotide sequences coding polypeptide for use in treatment and prevention of rheumatoid arthritis, myelomas, osteoporosis, sepsis, osteoarthritis, allergies and inflammatory bowel disease |
| 05/03/2005 | US6887675 For diagnosis/treatment of disease; drug screening cell cylce modulators/ADP-ribosyltransferase activity |
| 05/03/2005 | US6887674 Artery- and vein-specific proteins and uses therefor |
| 05/03/2005 | US6887672 Anti-equine Fc epsilon receptor alpha chain antibodies and methods to detect IgE |
| 05/03/2005 | US6887663 Vaccines for diagnosis/prevention/attenuation of infection; genetic engineering |
| 05/03/2005 | US6887659 A quantitative analyzing the concentration of peptide with monoclonal antibody produced by the fused cell hybrid; medical diagnosis |
| 05/03/2005 | US6887498 Method of making Bowman-Birk inhibitor product |
| 05/03/2005 | US6887477 Method of treating ischemic disease by intramuscular administration of Hepatocyte growth factor |
| 05/03/2005 | US6887476 Method for treating pain with botulinum toxin type B |
| 05/03/2005 | US6887475 Administering isolated Notch ligand comprising a DSL domain, wherein isolated Notch ligand is Serrate, wherein isolated Notch ligand interacts with a Notch receptor, wherein T-cell activation occurs with allergy or graft rejection |
| 05/03/2005 | US6887474 Compositions and methods for producing vascular occlusion |
| 05/03/2005 | US6887473 Administering as antitumor, antimetastasis, antiinflammatory, or anticarcinogenic agent |
| 05/03/2005 | US6887471 Method to inhibit T cell interactions with soluble B7 |
| 05/03/2005 | US6887470 Covalently bonding albumin to oligopeptide; biochemical conjugation; analyzing stability |
| 05/03/2005 | US6887469 Anti-idiotypic antibodies of vascular endothelial growth factor and use thereof as drugs |
| 05/03/2005 | US6887466 Activating the population of T cells and stimulating an accessory molecule on the surface of the T cells with a ligand; HIV immunotherapy; T cells can be genetically transduced and used for immunotherapy |
| 05/03/2005 | US6887463 Recombinant viral vector encoding a human very low density lipoprotein (VLDL) receptor, operatively linked to regulatory sequences directing expression in a hepatocyte; familial hypercholesterolemia or hyperlipidemia |
| 05/03/2005 | US6887462 For diagnosis, prevention, or treatment of diseases responsive to therapy with interferon- beta (IFN-beata) |
| 05/03/2005 | US6887461 Method of using IL-11 for treating mucositis |
| 05/03/2005 | CA2355657C Biodegradable ph/thermosensitive hydrogels for sustained delivery of biologically active agents |
| 05/03/2005 | CA2294686C Malleable paste for filling bone defects |
| 05/03/2005 | CA2245397C Antitumor agent |
| 05/03/2005 | CA2147623C Novel p-selectin ligand protein |
| 05/03/2005 | CA2128215C Autotaxin: motility stimulating protein useful in cancer diagnosis and therapy |
| 04/30/2005 | CA2553542A1 Methods and formulations for protecting cells, and for treating diseases and conditions by optimizing the intracellular concentration of nad |
| 04/28/2005 | WO2005038056A1 Combination therapy for the treatment of viral diseases |
| 04/28/2005 | WO2005038028A1 Poxvirus vector encoding retrovirus (eg hiv) and cytokine |
| 04/28/2005 | WO2005038022A1 Bone and/or joint disease-associated gene |
| 04/28/2005 | WO2005038019A1 Method for producing gamma-carboxylated proteins |
| 04/28/2005 | WO2005038006A2 Chimeric metabotropic glutamate receptors and uses thereof |
| 04/28/2005 | WO2005038000A2 T cell epitopes useful in mycobacterium tuberculosis vaccine and as diagnostic tools and methods for identifying same |
| 04/28/2005 | WO2005037999A2 Treatment of cancer using antibodies to lrrc15 |
| 04/28/2005 | WO2005037996A2 In vitro development of tissues and organs |
| 04/28/2005 | WO2005037990A2 Use of parp inhibitors for prevention and treatment of diabetic and insulin resistance complications |
| 04/28/2005 | WO2005037989A2 Binding domain-immunoglobulin fusion proteins |
| 04/28/2005 | WO2005037868A2 Methods of treating nfat-related disorders |
| 04/28/2005 | WO2005037865A2 Ztnfr14, A TUMOR NECROSIS FACTOR RECEPTOR |
| 04/28/2005 | WO2005037864A1 Novel protein and production process and use thereof |
| 04/28/2005 | WO2005037862A1 Targeting compositions and preparation thereof |
| 04/28/2005 | WO2005037861A1 Compound and method of treatment |
| 04/28/2005 | WO2005037860A2 Inhibitors of serine proteases, particularly hcv ns3-ns4a protease |
| 04/28/2005 | WO2005037855A2 T cell epitopes useful in a yersinia pestis vaccine and as diagnostic tools and methods for identifying same |
| 04/28/2005 | WO2005037336A1 Hydrogel-containing medical articles and methods of using and making the same |
| 04/28/2005 | WO2005037317A2 Mast cell-derived renin |
| 04/28/2005 | WO2005037308A1 Methods and agents for the treatment of cancer |
| 04/28/2005 | WO2005037307A1 Use of growth hormone releasing factor analogs in treating patients suffering from wasting |
| 04/28/2005 | WO2005037306A1 Combination therapy |
| 04/28/2005 | WO2005037305A1 Therapeutic uses of chemokine variants |
| 04/28/2005 | WO2005037304A1 Treatment and prevention of decubitus |
| 04/28/2005 | WO2005037303A1 Methods and compositions of ig20 and denn-sv splice variants |
| 04/28/2005 | WO2005037302A1 Stabilization of pharmaceutical protein formulations with small peptides |
| 04/28/2005 | WO2005037301A1 Treatment of cognitive dysfunction un lupus |
| 04/28/2005 | WO2005037297A1 Compositions and methods for inhibiting cell senescence and hyperproliferative disorders |
| 04/28/2005 | WO2005037293A1 Immunomodulating compositions and uses therefor |
| 04/28/2005 | WO2005037274A1 Combination therapy for hcv infection |
| 04/28/2005 | WO2005037248A1 Glycoprotein and/or glycomacropeptide containing preparations for medical uses |
| 04/28/2005 | WO2005037236A2 Novel heat shock protein 20-related polypeptides and uses therefor |
| 04/28/2005 | WO2005037232A2 Methods and compositions for modulating adipocyte function |
| 04/28/2005 | WO2005037225A2 Methods for treating disorders of neuronal deficiency with bone marrow-derived cells |
| 04/28/2005 | WO2005037221A2 Cystatin c as an antagonist of tgf-b and methods related thereto |
| 04/28/2005 | WO2005037214A2 Macrocyclic carboxylic acids and acylsulfonamides as inhibitors of hcv replication |
| 04/28/2005 | WO2005037203A2 Methods and reagents for the treatment of immunoinflammatory disorders |
| 04/28/2005 | WO2005037202A2 Methods for modulating angiogenesis |
| 04/28/2005 | WO2005037194A2 Collagen interactions with prostate cancer cells |
| 04/28/2005 | WO2005036989A1 Health food containing hyaluronic acid and dermatan sulfate |
| 04/28/2005 | WO2005026204A3 Synthetic antimicrobial polypeptides |
| 04/28/2005 | WO2005025553A3 Treatment of disorders of nervous systemsystem with fty720 |
| 04/28/2005 | WO2005024059A3 Methods for identifying compounds for inhibiting fever |
| 04/28/2005 | WO2005023826A3 Polymorphic nucleoside compounds |
| 04/28/2005 | WO2005023291A3 Use of glp1-agonists in the treatment of patients with type i diabetes |
| 04/28/2005 | WO2005014032B1 Use of secretagogues like ghrelin in cancer cachexia and for stimulating appetite |
| 04/28/2005 | WO2005012348A3 Cyclic cadherin analogues comprising the sequence hav for modulating the migration of vascular smooth muscle cells |
| 04/28/2005 | WO2005010165A3 Non-glycosylated human alpha-fetoprotein, methods of production, and uses thereof |
| 04/28/2005 | WO2005007811A3 Injection of bone marrow-derived cells and medium for angiogenesis |
| 04/28/2005 | WO2005003292A3 Composition and method for self-assembly and mineralization of peptide amphiphiles |
| 04/28/2005 | WO2004112820A3 Peptides and peptidomimetics having immune-modulating, anti-inflammatory, and anti-viral activity |